Ofatumumab 100mg/5ml solution for infusion vials

SNOMED code
17190711000001109
Active compound
Ofatumumab
Preferred name basis
rINN - Recommended International Non-proprietary
Prescribable
✅ Yes
Non-availability
Actual Products not Available
Non-availability date
Dose form
Discrete
Dose size and units
5 ml, vial
Ingredients
Ofatumumab — 20 mg / 1 ml based on ingredient substance
Form & Route
solutioninfusion.intravenous
Solution for infusion, Intravenous
Controlled drug
No Controlled Drug Status

Products

Arzerra 100mg/5ml concentrate for solution for infusion vials (Novartis Pharmaceuticals UK Ltd)

in short Arzerra 100mg/5ml concentrate for inf vials

Arzerra 100mg/5ml concentrate for solution for infusion vials

SNOMED code
17191011000001103
Supplier
Novartis Pharmaceuticals UK Ltd
Licensed as
Medicines - MHRA/EMA
Availability restrictions
Not available
Licensed route
Intravenous
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Arzerra 100mg/5ml concentrate for solution for infusion vials (Novartis Pharmaceuticals UK Ltd) 3 vial
17191111000001102   ref. pack
Discontinued


Legal category: POM
5000123112975

End: 5000123113880

End: 5010678901061
No Price Available
 
previously: £546
• Hospital
  • • Prescription Charges
Arzerra 100mg/5ml concentrate for solution for infusion vials (Novartis Pharmaceuticals UK Ltd) 10 vial
17191311000001100   ref. pack
Discontinued


Legal category: POM
5000123112982
No Price Available
• Hospital
  • • Prescription Charges

Reference packs

Ofatumumab 100mg/5ml solution for infusion vials 3 vial
SNOMED code
17190811000001101
Quantity and unit
3 vial
Packs
Ofatumumab 100mg/5ml solution for infusion vials 10 vial
SNOMED code
17190911000001106
Quantity and unit
10 vial
Packs